Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2018

Jun 21, 2018

30145_dirs_2018-06-21_d44d6d66-28e3-4af1-9f38-2f93d6328973.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2018-06-19

Reporting Person: Wheatley Timothy Alan (Segment President, Retail)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-19 Humana Common M 459 $217.415 Acquired 3889 Direct
2018-06-19 Humana Common M 8136 $164.645 Acquired 12025 Direct
2018-06-19 Humana Common M 3873 $217.415 Acquired 15898 Direct
2018-06-19 Humana Common S 11468 $299.3959 Disposed 4430 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-06-19 Options $164.645 M 8136 Disposed 2022-02-24 Humana Common (8136) Direct
2018-06-19 Options $217.415 M 4332 Disposed 2024-03-08 Humana Common (4332) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 757 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options $167.805 2023-02-18 Humana Common (8010) 8010 Direct
Options $268.47 2025-02-19 Humana Common (6623) 6623 Direct
Options $271.14 2025-03-01 Humana Common (1391) 1391 Direct
Restricted Stock Units $ Humana Common (870) 870 Direct
Restricted Stock Units $ Humana Common (3717) 3717 Direct
Restricted Stock Units $ Humana Common (1536) 1536 Direct
Restricted Stock Units $ Humana Common (323) 323 Direct
Phantom Stock Units $ Humana Common (117) 117 Indirect

Footnotes

F1: Shares held for the benefit of reporting person as of May 31, 2018 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/24/2015, vesting in three increments from 02/24/2016 to 02/24/2018.

F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/18/2016, vesting in three increments from 02/18/2017 to 02/18/2019.

F4: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 7,499 options fully vest three years from the date of grant.

F5: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 02/19/2019 to 02/19/2021.

F6: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 3/1/19 to 3/1/21.

F7: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/2017 and 12/15/2018.

F9: Restricted stock units granted to reporting person on 03/08/17, 2,989 shares vesting in three annual increments on 12/15/17, 12/15/18, and 12/15/19. 1,724 shares fully vest three years from the date of grant.

F10: Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20.

F11: Restricted stock units granted to reporting person on 03/1/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20.

F12: Phantom Stock Units held for the benefit of reporting person as of May 31, 2018 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F13: Shares sold at prices ranging from $299.30 to $299.47. Price reported is weighted average sales price.